Published in Mol Microbiol on September 02, 2011
Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection. Infect Immun (2012) 1.53
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15
A bacterial virulence protein promotes pathogenicity by inhibiting the bacterium's own F1Fo ATP synthase. Cell (2013) 1.11
RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073. MBio (2013) 0.92
Bacterial Mg2+ homeostasis, transport, and virulence. Annu Rev Genet (2013) 0.91
The transcriptional regulator CzcR modulates antibiotic resistance and quorum sensing in Pseudomonas aeruginosa. PLoS One (2012) 0.91
A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog (2013) 0.90
Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog (2015) 0.89
Identification of novel factors involved in modulating motility of Salmonella enterica serotype typhimurium. PLoS One (2014) 0.88
When Too Much ATP Is Bad for Protein Synthesis. J Mol Biol (2015) 0.86
Flagella-independent surface motility in Salmonella enterica serovar Typhimurium. Proc Natl Acad Sci U S A (2015) 0.86
Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol Spectr (2015) 0.85
Escherichia coli isolate for studying colonization of the mouse intestine and its application to two-component signaling knockouts. J Bacteriol (2014) 0.82
Identification of DNA binding motifs of the Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system. PLoS One (2012) 0.81
Metabolism and Fitness of Urinary Tract Pathogens. Microbiol Spectr (2015) 0.81
A Shigella flexneri virulence plasmid encoded factor controls production of outer membrane vesicles. G3 (Bethesda) (2014) 0.79
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Cyclic diguanylate signaling in Gram-positive bacteria. FEMS Microbiol Rev (2016) 0.77
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections. Microbiol Spectr (2016) 0.77
Evidence that bacteriophage λ lysogens may induce in response to the proton motive force uncoupler CCCP. FEMS Microbiol Lett (2015) 0.75
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Drug Des Devel Ther (2016) 0.75
A predictor for predicting Escherichia coli transcriptome and the effects of gene perturbations. BMC Bioinformatics (2014) 0.75
A trans-acting leader RNA from a Salmonella virulence gene. Proc Natl Acad Sci U S A (2017) 0.75
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci U S A (1986) 14.31
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med (1978) 11.45
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc Natl Acad Sci U S A (1989) 9.79
Host controlled variation in bacterial viruses. J Bacteriol (1953) 9.46
A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science (1989) 7.58
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry (1974) 6.97
Mg2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell (1996) 6.19
Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem (2008) 5.94
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol (1998) 5.01
Escherichia coli acid resistance: tales of an amateur acidophile. Nat Rev Microbiol (2004) 4.95
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun (1990) 4.94
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science (1997) 4.81
Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell (2005) 4.78
Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci U S A (1992) 4.72
Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med (2000) 3.91
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci U S A (1997) 3.71
CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol (2006) 3.60
Molecular basis of the magnesium deprivation response in Salmonella typhimurium: identification of PhoP-regulated genes. J Bacteriol (1996) 3.09
Regulation of nonspecific acid phosphatase in Salmonella: phoN and phoP genes. J Bacteriol (1979) 3.09
A bacterial virulence determinant encoded by lysogenic coliphage lambda. Nature (1990) 3.02
Modulation of Shigella virulence in response to available oxygen in vivo. Nature (2010) 2.96
An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J Biol Chem (2001) 2.95
A signal transduction system that responds to extracellular iron. Cell (2000) 2.91
Inducible prophages contribute to Salmonella virulence in mice. Mol Microbiol (1999) 2.70
Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J (2000) 2.64
Mode of action of the antimicrobial peptide indolicidin. J Biol Chem (1996) 2.57
Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate. J Biol Chem (1999) 2.56
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses (1995) 2.53
Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol (2001) 2.53
The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature (2003) 2.45
The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol Microbiol (2000) 2.40
Dissecting the PhoP regulatory network of Escherichia coli and Salmonella enterica. Proc Natl Acad Sci U S A (2005) 2.40
A biological role for prokaryotic ClC chloride channels. Nature (2002) 2.36
Micromolar intracellular hydrogen peroxide disrupts metabolism by damaging iron-sulfur enzymes. J Biol Chem (2006) 2.34
Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med (1997) 2.34
Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb Pathog (1989) 2.32
High levels of intracellular cysteine promote oxidative DNA damage by driving the fenton reaction. J Bacteriol (2003) 2.26
Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun (1990) 2.25
Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry (1995) 2.18
A low pH-inducible, PhoPQ-dependent acid tolerance response protects Salmonella typhimurium against inorganic acid stress. J Bacteriol (1998) 2.15
Escherichia coli glutamate- and arginine-dependent acid resistance systems increase internal pH and reverse transmembrane potential. J Bacteriol (2004) 2.14
pH sensing by intracellular Salmonella induces effector translocation. Science (2010) 2.13
The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun (2000) 2.10
Identification and molecular characterization of the Mg2+ stimulon of Escherichia coli. J Bacteriol (2003) 2.06
Holins kill without warning. Proc Natl Acad Sci U S A (2001) 2.05
Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol (2003) 2.01
Activation of the bacterial sensor kinase PhoQ by acidic pH. Mol Cell (2007) 1.98
The proton pump is a molecular engine of motile bacteria. Nature (1978) 1.96
Proton motive force and the physiological basis of delta pH maintenance in thiobacillus acidophilus. J Bacteriol (1982) 1.86
PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar typhimurium. J Bacteriol (2007) 1.70
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67
A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose. J Biol Chem (2005) 1.66
Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood (2003) 1.63
Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli. J Biol Chem (2004) 1.50
Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes. Proc Natl Acad Sci U S A (2004) 1.50
Magnesium transporters: properties, regulation and structure. Front Biosci (2006) 1.49
The cell membrane plays a crucial role in survival of bacteria and archaea in extreme environments. Antonie Van Leeuwenhoek (2002) 1.47
A potential role for periplasmic superoxide dismutase in blocking the penetration of external superoxide into the cytosol of Gram-negative bacteria. Mol Microbiol (2002) 1.42
Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium. J Mol Evol (2005) 1.41
The protonmotive force and beta-galactoside transport in Bacillus acidocaldarius. J Biol Chem (1978) 1.40
Proton secretion by stimulated neutrophils. Significance of hexose monophosphate shunt activity as source of electrons and protons for the respiratory burst. J Clin Invest (1984) 1.35
Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol (2001) 1.30
Generation of a large, protonophore-sensitive proton motive force and pH difference in the acidophilic bacteria Thermoplasma acidophilum and Bacillus acidocaldarius. J Bacteriol (1985) 1.27
The phage shock protein PspA facilitates divalent metal transport and is required for virulence of Salmonella enterica sv. Typhimurium. Mol Microbiol (2010) 1.18
PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis (2004) 1.13
Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology (2006) 1.10
Respiration of Escherichia coli can be fully uncoupled via the nonelectrogenic terminal cytochrome bd-II oxidase. J Bacteriol (2009) 1.08
Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07
pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine. J Bacteriol (2007) 1.04
Protecting against antimicrobial effectors in the phagosome allows SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium. J Bacteriol (2010) 1.00
Salmonella enterica serovar Typhimurium periplasmic superoxide dismutase SodCI is a member of the PhoPQ regulon and is induced in macrophages. J Bacteriol (2006) 0.93
Role of flavin mononucleotide in the thermostability and oligomerization of Escherichia coli stress-defense protein WrbA. Biochemistry (2007) 0.92
Enzymology of lipid A palmitoylation in bacterial outer membranes. J Endotoxin Res (2004) 0.78
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol (2007) 2.50
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog (2009) 2.14
Host-pathogen interactions in urinary tract infection. Nat Rev Urol (2010) 1.94
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun (2005) 1.80
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun (2004) 1.76
Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res (2002) 1.69
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67
Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog (2010) 1.65
Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun (2007) 1.60
Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect Immun (2002) 1.56
Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun (2002) 1.56
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol (2010) 1.55
Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun (2007) 1.50
The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun (2005) 1.49
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol (2012) 1.48
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun (2011) 1.44
Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun (2011) 1.41
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun (2004) 1.36
Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol (2009) 1.34
Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun (2005) 1.32
Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media. J Clin Microbiol (2006) 1.29
Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol Microbiol (2008) 1.25
complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol (2007) 1.24
Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect Immun (2002) 1.22
In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infect Immun (2002) 1.21
Transcriptome of swarming Proteus mirabilis. Infect Immun (2010) 1.19
Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun (2003) 1.16
Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol (2011) 1.15
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells. PLoS Pathog (2013) 1.14
Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol (2002) 1.14
Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect Immun (2006) 1.14
Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog (2013) 1.10
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines (2012) 1.10
Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity. J Infect Dis (2013) 1.09
The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J Immunol (2010) 1.09
Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol (2008) 1.08
A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol Microbiol (2008) 1.07
Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun (2004) 1.07
Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio (2010) 1.07
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun (2012) 1.06
Helicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane protein. Infect Immun (2006) 1.04
Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae. J Bacteriol (2008) 1.04
The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection. J Med Microbiol (2007) 1.04
Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio (2011) 1.04
Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun (2006) 1.03
The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol (2002) 1.03
Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun (2004) 1.03
Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect Immun (2010) 1.01
PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect Immun (2008) 1.00
Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis. Infect Immun (2010) 0.99
Urease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor. Infect Immun (2002) 0.98
Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance. J Infect Dis (2009) 0.98
Determination of target sequence bound by PapX, repressor of bacterial motility, in flhD promoter using systematic evolution of ligands by exponential enrichment (SELEX) and high throughput sequencing. J Biol Chem (2011) 0.96
Vaccines for Proteus mirabilis in urinary tract infection. Int J Antimicrob Agents (2002) 0.96
Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Mol Microbiol (2008) 0.96
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio (2012) 0.95
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun (2008) 0.95
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect Immun (2009) 0.94
Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection. MBio (2012) 0.94
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect Immun (2013) 0.93
Uropathogenic Escherichia coli strains generally lack functional Trg and Tap chemoreceptors found in the majority of E. coli strains strictly residing in the gut. J Bacteriol (2006) 0.92
Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infect Immun (2011) 0.91
The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol (2008) 0.91
Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infect Immun (2009) 0.91
Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression. Infect Immun (2011) 0.90
Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection. Infect Immun (2008) 0.90
Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J Bacteriol (2008) 0.90
UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections. Infect Immun (2003) 0.89
Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. J Microbiol Methods (2009) 0.88
Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis (2011) 0.87
Self-transmissibility of the integrative and conjugative element ICEPm1 between clinical isolates requires a functional integrase, relaxase, and type IV secretion system. J Bacteriol (2011) 0.87
Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis. Mol Microbiol (2010) 0.86
Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis. MBio (2012) 0.86
An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol (2009) 0.85
Initiation of swarming motility by Proteus mirabilis occurs in response to specific cues present in urine and requires excess L-glutamine. J Bacteriol (2013) 0.85
Involvement of mismatch repair in the reciprocal control of motility and adherence of uropathogenic Escherichia coli. Infect Immun (2012) 0.85
Virulence and Fitness Determinants of Uropathogenic Escherichia coli. Microbiol Spectr (2015) 0.85
Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS. Microbiology (2003) 0.84
Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics (2015) 0.83